Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

Microbiology Spectrum(2022)10.1128/spectrum.01538-22Source: DataRank Database

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice is a research paper published in Microbiology Spectrum (2022). On theSindex it has a DataRank of 0. It has been cited 42 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access42 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 3.77)OA: goldTopics (61)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

José Luis Martínez ORCID,Stefan Slamanig ORCID,Nicholas Lemus ORCID,Yonghong Liu ORCID,Tsoi Ying Lai

Live enrichment

PubMed:35658571 PMC:PMC9241906 OpenAlex:https://openalex.org/W4282000511

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400008C

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: 75N93021C00014

HHS | National Institutes of Health

Grant: DK130425/DK/NIDDK

HHS | NIH | National Institute of Allergy and Infectious Diseases

Grant: NIAID R21AI157606

Anonymous philanthropist to Mount Sinai

Grant: -

NIDDK NIH HHS

Grant: R01 DK130425

NIAID NIH HHS

Grant: R21 AI157606

National Institutes of Health

Grant: 7R21AI157606-02

Exosome-display as a strategy to enhance the immunogenicity of SARS-CoV-2 vaccines based on adenoviral vectors

National Institutes of Health

Grant: 1R01DK130425-01

Experimental and natural SARS-CoV-2 infection of the human pancreas

FWCI

3.77

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://doi.org/10.1128/spectrum.01538-22

publisherhttps://doi.org/10.1128/spectrum.01538-22

publisherhttps://journals.asm.org/doi/pdf/10.1128/spectrum.01538-22

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35658571

repositoryhttps://doaj.org/article/68d6371506a14ab1b92c04ed3d25e92f

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches0301 basic medicine03 medical and health sciencesAnimalsAntibodies, NeutralizingAntibodies, ViralBroadly Neutralizing AntibodiesCOVID-19COVID-19 VaccinesHumansMiceNewcastle disease virusSARS-CoV-2Spike Glycoprotein, CoronavirusSARS-CoV-2 variants

MeSH Terms

Broadly Neutralizing AntibodiesCOVID-19SARS-CoV-2COVID-19 VaccinesAnimalsAntibodies, ViralHumansNewcastle disease virusMiceAntibodies, NeutralizingSpike Glycoprotein, Coronavirus

Keywords

Newcastle diseaseVirologySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirusCoronavirus disease 2019 (COVID-19)Biology2019-20 coronavirus outbreakConstruct (python library)DiseaseMedicineInfectious disease (medical specialty)Computer scienceOutbreakCross-protectionPandemic PreparednessMultivalent vaccineNeutralizing AntibodiesLow-cost Vaccine PlatformCOVID-19 VaccinesSARS-CoV-2Newcastle disease virusCOVID-19Antibodies, ViralMicrobiologyAntibodies, NeutralizingQR1-502ArticleMiceSpike Glycoprotein, CoronavirusAnimalsHumansBroadly Neutralizing AntibodiesResearch Article

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Additional file 6 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.26677373.v1figshare

10.6084/m9.figshare.26677373figshare

Additional file 5 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.26677370.v1figshare

10.6084/m9.figshare.26677370figshare

Additional file 4 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.26677367.v1figshare

10.6084/m9.figshare.26677367figshare

Additional file 3 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.26677364.v1figshare

10.6084/m9.figshare.26677364figshare

Additional file 2 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.25150733.v1figshare

10.6084/m9.figshare.25150733figshare

Additional file 1 of Use of live attenuated recombinant Newcastle disease virus carrying avian paramyxovirus 2 HN and F protein genes to enhance immune responses against species A rotavirus VP6 protein

10.6084/m9.figshare.25150602.v1figshare

10.6084/m9.figshare.25150602figshare

Trivalent NDV-HXP-S Vaccine Protects against Phylogenetically Distant SARS-CoV-2 Variants of Concern in Mice

FAIR Checklist

Authors (17)

Funding (9 grants)

Impact

Open Access

Topics

Linked Datasets (12)

Annotations (Europe PMC)